We analyzed data from 129 patients enrolled on 19 lung cancer trials with mandatory or optional tumor tissue submission to determine impact of these requirements on treatment timelines and staff effort. On average, tissue requirements delayed treatment initiation 21 days and required 3 staff communications. Improved systems to expedite these processes and use of non-tissue-based biomarkers may address these issues.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2q0bCWz
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction che...
-
Abstract Purpose Overcoming the flaws of current data management conditions in head and neck oncology could enable integrated informatio...
-
Differential Evolution Optimization of the SAR Distribution for Head and Neck Hyperthermia. IEEE Trans Biomed Eng. 2016 Nov 14;: Auth...
-
Rahul Nagar Indian Journal of Dermatology, Venereology, and Leprology 2017 83(3):290-297 Autophagy, literally meaning “self-eating,” is ...
-
This paper investigates the control and synchronization of a class of chaotic systems with switched output which is assumed to be switched b...
-
Liver ischemia reperfusion injury (IRI) is inevitable during transplantation and resection and is characterized by hepatocellular injury. Th...
-
Photochem. Photobiol. Sci. , 2017, Accepted Manuscript DOI : 10.1039/C7PP00164A, Paper Yuta Shamoto, Mikio Yagi, Nozomi Oguchi-Fujiyama, K...
-
RT @ecancer_espanol : Abiraterone for metastatic, hormone sensitive, prostate cancer https://t.co/xa9jVlFrCg https://t.co/dj5XAacWCF fro...
-
Melanocyte development is orchestrated by a complex interconnecting regulatory network of genes and synergistic interactions. Piebaldism and...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου